🇺🇸 FDA
Patent

US 10246505

Chimeric antigen receptors to control HIV infection

granted A61KA61K48/005

Quick answer

US patent 10246505 (Chimeric antigen receptors to control HIV infection) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K48/005